Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis

Human Pathology

Volumn 37, Issue 1, 2006, Pages 16-22

  Parenti, Anna ^a   Leo, Genesio ^a   Porzionato, Andrea ^a   Zaninotto, Giovanni ^a   Rosato, Antonio ^a   Ninfo, Vito ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Barrett's esophagus; Caspase 3; Esophageal dysplasia; Immunohistochemistry; Survivin

Indexed keywords

ANTIBODY; CASPASE 3; PROTEIN P53; SURVIVIN;

ANTIBODY DETECTION; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REACTION TIME; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BARRETT ESOPHAGUS; CASPASE 3; CASPASES; CELL PROLIFERATION; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 29044451059     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.10.003     Document Type: Article

References (37)

1. N.E. Crook, R.J. Clem, and L.K. Miller An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif J Virol 67 1993 2168 2174
2. F. Li, G. Ambrosiani, and E.Y. Chu Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
3. C. Adida, D. Berrebi, and M. Peuchmaur Anti-apoptosis gene, survivin, and prognosis of neuroblastoma Lancet 351 1998 882 883
4. P. Grabowski, T. Kuhnel, and F. Muhr-Wilkenshoff Prognostic value of nuclear survivin expression in esophageal squamous cell carcinoma Br J Cancer 88 2003 115 119
5. M. Ikeguchi, K. Yamaguchi, and N. Kaibara Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer Tumor Biol 24 2003 40 45
6. L. Lo Muzio, G. Pannone, and S. Staibano Survivin expression in oral squamous cell carcinoma Br J Cancer 89 2003 2244 2248
7. H. Kawasaki, D.C. Altieri, and C.D. Lu Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res 58 1998 5071 5074
8. M. Monzo, R. Rosell, and E. Felip A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers J Clin Oncol 17 1999 2100 2104
9. K. Tanaka, S. Iwamoto, and G. Gon Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 2000 127 134
10. M. Frost, E.A. Jarboe, and D. Orlicky Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma Am J Clin Pathol 117 2002 738 744
11. R. Gianani, E. Jarboe, and D. Orlicky Expression of survivin in normal, hyperplastic and neoplastic colonic mucosa Hum Path 32 2001 119 125
12. C. Chiodino, A.M. Cesinaro, and D. Ottani Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin J Invest Dermatol 113 1999 415 418
13. D. Grossman, J.M. McNiff, and F. Li Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line Lab Invest 79 1999 1121 1126
14. L. Lo Muzio, G. Pannone, and R. Leonardi Survivin, a potential early predictor of tumor progression in the oral mucosa J Dent Res 82 2003 923 928
15. C.D. Lu, D.C. Altieri, and N. Tanigawa Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas Cancer Res 58 1998 1808 1812
16. A.R. Parenti, M. Rugge, and E. Frizzera p53 overexpression in the multistep process of oesophageal carcinogenesis Am J Surg Pathol 19 1995 1418 1422
17. L.J. Lin, C.Q. Zheng, and Y. Jin Expression of survivin protein in human colorectal carcinogenesis World J Gastroenterol 9 2003 974 977
18. F. Li, J. Yang, and N. Ramnath Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 114 2005 509 512
19. P. Campomenosi, M. Conio, and M. Bogliolo p53 is frequently mutated in Barrett's metaplasia of the intestinal type Cancer Epidemiol Biomarkers Prev 5 1996 559 565
20. F. Segal, A.P. Kaspary, and J.C. Prolla p53 protein overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barrett's esophagus Cancer Lett 210 2004 213 218
21. A. Suspiro, A.D. Pereira, and A. Alfonso Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma Am J Gastroenterol 98 2003 728 734
22. S. Ramel, B.J. Reid, and C.A. Sanchez Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry Gastroenterology 102 1992 1220 1228
23. M. Younes, R.M. Lebovitz, and L.V. Lechago p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study Gastroenterology 105 1993 1637 1642
24. K.K. Krishnadath, H.W. Tilanus, and M. van Blakenstein Accumulation of p53 protein in normal, dysplastic and neoplastic Barrett's oesophagus J Pathol 175 1995 175 180
25. C. Ferec, M.P. Audrezet, and B. Mercier TP53 gene alterations during neoplastic progression of Barrett's mucosa Gastroenterol Clin Biol 18 1994 D46 D51
26. R.H. Hardwick, N.A. Shepherd, and M. Moorghen Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence Gut 35 1994 764 768
27. D.S. Levine Barrett's oesophagus and p53 Lancet 344 1994 212 213
28. P.L. Blount, P.C. Galipeau, and C.A. Sanchez 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy Cancer Res 54 1994 2292 2295
29. K. Neshat, C.A. Sanchez, and P.C. Galipeau p53 mutation in Barrett's adenocarcinoma and high-grade dysplasia Gastroenterology 106 1994 1589 1595
30. W.H. Hoffman, S. Biade, and J.T. Zilfou Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 J Biol Chem 277 2002 3247 3257
31. A. Mirza, M. McGuirk, and T.N. Hockenberry Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway Oncogene 21 2002 2613 2622
32. M. Zhou, L. Gu, and F. Li DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells J Pharmacol Exp Ther 303 2002 124 131
33. J.Y. Hsia, C.Y. Chen, and J.T. Chen Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma EJSO 29 2003 44 48
34. Y.H. Li, C. Wang, and K. Meng Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma World J Gastroenterol 10 2004 1984 1988
35. J.X. Wang, and S. Zheng Caspase-3 and survivin expression in pediatric neuroblastoma and their roles in apoptosis Chin Med J 117 2004 1821 1824
36. N. Isobe, H. Onodera, and A. Mori Caspase-3 expression in human gastric carcinoma and its clinical significance Oncology 66 2004 201 209
37. Z. Estrov, P.F. Thall, and M. Talpaz Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia Blood 92 1998 3090 3097